Am J Transplant, Volume 19, Suppl 3 Archives - Page 130 of 214 - ATC Abstracts

2019 American Transplant Congress
Modeling Patients as Dynamical Systems: Evaluating the Efficiency of Kidney Transplantation through Multi-Stage Data Envelopment Analysis
F. J. Santos Arteaga¹, D. Di Caprio², D. Cucchiari³, J. M. Campistol³, F. Oppenheimer³, F. Diekmann³, I. Revuelta³
¹Faculty of Economics and Management, Free University of Bolzano, Bolzano, Italy, ²Department of Mathematics and Statistics, York University, Toronto, ON, Canada, ³Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain
*Purpose: The occurrence of kidney graft loss is determined by a large set of variables interacting across the different stages of the transplantation process. This…
2019 American Transplant Congress
Clinical Utility of the Edmonton Symptom Assessment System to Screen for Depression and Anxiety in Kidney Transplant Recipients
E. Tang, S. Dano, A. Ayub, V. Li, I. Escudero, N. Ullah, N. Edwards, M. Novak, I. Mucsi
University Health Network, Toronto, ON, Canada
*Purpose: Anxiety and depression are frequent concerns in kidney transplant recipients and are associated with non-adherence and worse clinical outcomes. However, they are often underrecognized…
2019 American Transplant Congress
Impact of Transplant Ureteral Stricture Location and Type of Ureteral Revision on Long-Term Graft Survival and Patient Outcomes in Kidney Transplantation
C. Shepherd¹, R. Cameron², C. Holbrooks², A. Lin³, S. Nadig³, J. McGillicuddy³, D. Dubay³, D. Taber³, P. Baliga³, V. Rohan³
¹Urology, Medical University of South Carolina, Charleston, SC, ²College of Medicine, Medical University of South Carolina, Charleston, SC, ³Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Transplant ureteral strictures are a major cause of morbidity following kidney transplantation and often require surgical revision including ureteroureterostomy (UU) and neocystoureterostomy (NC). Our…
2019 American Transplant Congress
Analysis of Lactic Acid Response in Renal Transplant Patients
A. A. Henderson¹, H. Ahmed², M. R. Wakefield¹
¹Surgery/Urology, University of Missouri School of Medicine, Columbia, MO, ²University of Missouri School of Medicine, Columbia, MO
*Purpose: Lactic acid (LA) serves as an important biomarker in the evaluation of ischemia, sepsis, metabolic acidosis, and trauma. During renal transplantation (RT), there is…
2019 American Transplant Congress
Utility of a Novel dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients
J. Peabody¹, P. Billings², Z. Demko², D. Paculdo¹, M. Tran¹, S. Moshkevich², C. Valdenor¹
¹QURE Healthcare, San Francisco, CA, ²Natera, Inc., San Carlos, CA
*Purpose: Detecting allograft injury and rejection is critical to preventing graft loss. Current standard of care (SoC) relies on serum creatinine (SC) and biopsy to…
2019 American Transplant Congress
Effect of Renal Function on Asymmetric Dimethylarginine (ADMA) Homeostasis in Kidney Donors and Recipients
M. Y. Said¹, R. M. Douwes¹, M. van Londen¹, I. Minović¹, A. Frenay², M. H. de Borst¹, E. van den Berg¹, M. R. Heiner-Fokkema³, A. A. Kayacelebi⁴, A. Bollenbach⁴, H. van Goor⁵, G. J. Navis¹, D. Tsikas⁴, S. J. Bakker¹
¹Internal medicine, University Medical Center Groningen, Groningen, Netherlands, ²Gynecology and Obstetrics, Amsterdam University Medical Center, Amsterdam, Netherlands, ³Laboratory Medicine, University Medical Center Groningen, Groningen, Netherlands, ⁴Inst. of Toxicology, Core Unit Proteomics, Hannover Medical School, Hannover, Germany, ⁵Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands
*Purpose: ADMA is a methylated form of arginine and an endogenous nitric oxide synthase inhibitor. Plasma ADMA (pADMA) is known as a strong cardiovascular risk…
2019 American Transplant Congress
Partial Parathyroidectomy And Allograft Function In Renal Transplant Patients
M. Gao¹, E. Vilayur¹, D. Ferreira², C. Bendinelli¹, C. Sankoorikal¹
¹John Hunter Hospital, New Lambton Heights, Australia, ²Liverpool Hospital, Liverpool, Australia
*Purpose: Studies have previously shown that total parathyroidectomy in the renal transplant patient may adversely affect allograft function. The primary aim of this study was…
2019 American Transplant Congress
Long-term Impact of Antihypertensive Treatment and Tacrolimus Dose in Renal Allograft Recipients 5 Years Post-Transplantation
D. Rush¹, S. Cockfield², S. Wilson³, J. Schwartz⁴
¹University of Manitoba, Winnipeg, MB, Canada, ²University of Alberta Hopspital, Edmonton, AB, Canada, ³Astellas Pharma Global Development, Northbrook, IL, ⁴Astellas Pharma US, Northbrook, IL
*Purpose: Inflammation and fibrosis after renal transplantation may be modulated by optimizing tacrolimus exposure, or by use of angiotensin-converting enzyme inhibitors (ACEi), or angiotensin receptor…
2019 American Transplant Congress
The Utility of Donor and Recipient BK Virus Antibody Testing Prior to Renal Transplantation in Risk Assessment for Developing BK Viremia
N. Donmez, S. I. Al-Akash
Driscoll Children's Hospital, Corpus Christi, TX
*Purpose: The correlation between donor (DON) and recipient (REC) BKV antibody (AB) titers and BK viremia in renal transplant (RTx) has not been well-studied in…
2019 American Transplant Congress
Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute Cellular Compared to Chronic Active Antibody-Mediated Rejection
N. Borsum, T. Ahlenstiel-Grunow, L. Pape
Pediatric Nephrology, Hannover Medical School, Hannover, Germany
*Purpose: Until now, no blood biomarkers have been identified to enable early diagnosis of acute cellular or chronic active antibody-mediated rejection (cABMR) after pediatric kidney…